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During malignant melanoma (MM) progression including incipient metastasis, neoplastic cells follow some speciﬁc migration
paths inside the skin. In particular, they progress along the dermoepidermal basement membrane, the hair follicles, the sweat
gland apparatus, nerves, and the near perivascular space. These features evoke the thigmotropism phenomenon deﬁned as a
contact-sensing growth of cells. This process is likely connected to modulation in cell tensegrity (control of the cell shape). These
speciﬁcally located paucicellular aggregates of MM cells do not appear to be involved in the tumorigenic growth phase, but rather
they participate in the so-called “accretive” growth model. These MM cell collections are often part of the primary neoplasm, but
they may, however, correspond to MM micrometastases and predict further local overt metastasis spread.
1.Introduction
Cancer remains one of the most complex diseases and,
despite the impressive advances made in molecular and cell
biology, how cancer cells progress through cancerogenesis
and give rise to metastasis remains unsettled. Cancerogenesis
is a dynamic process that depends on a large number of
variables and is regulated at multiple spatial and temporal
scales [1]. The model of skin malignant melanoma (MM)
progression leading to tumorigenesis begins with a critical
step of malignancy corresponding to clonal generation of
cells capable of initiating a vertical growth phase [2]. Some
of these cells lead to advanced MM competent for metastasis.
Themostaggressiveclonesclearlyexhibitagrowthadvantage
over other cells [3–9] associated or not with selective ad-
vantages including migration [8–11]. This latter attribute of
MM cells has rarely been scrutinized in the literature.
A broad range of eukaryotic cells adjust their growth
direction according to physical and topographic attributes
of the surrounding environment [12–19]. The ability to
sense and respond to physical aspects of the organized
supporting substrate is indeed an adaptation of a large
number of tip growing cells living on and within solid
substrates. Such tropism behavior is known variously as
thigmotropism, contact-sensing growth, touch-sensitive
response, or contour guidance. Typical examples include
plant roots that reversibly rotate the root apex or achieve
the circumnavigation of obstacles while growing in soil
[15, 16]. Fungal growth is similarly under the inﬂuence of
thigmotropism [17, 18]. Another example is provided by
the guided growth of embryo axonal or dendritic processes
within solid embryonic or regenerating tissues to achieve the
innervation of speciﬁc sites [12, 19].
It is likely that some speciﬁc molecular components play
a part in directing cell growth [20]. When the cell contacts
an inductive surface, stretching of the cell membrane may
occur, during which channels open allowing eﬄux or inﬂux
of speciﬁc ions such as Ca2+ [21, 22]. As a result the
ion concentrations are modulated in the cytoplasm. This
processmayactivateacascadeofeventsproducingaresponse
including the cell shape control (cell tensegrity) [23] and/or
thigmotropic diﬀerentiation.
Cancerogenesis involves three successive steps, namely,
the initiation, promotion, and progression phases [24]. In
MM, we frame as an hypothesis that cell migration, thig-
motropism, and tensegrity are involved and linked at least in
part to tumor progression and cell migration. Cell mobility
and migration in combination with cell proliferation are
operative in both the primary lesion and in the metastatic
spread[4,7–11, 25–27].The morphologic plasticity reﬂected2 Dermatology Research and Practice
by MM cell tensegrity is probably closely associated as well
[28].
2. MigrationPaths and Contact-Sensing
Progression of MM Cells
MM cells are in essence capable of migration in a variety
of directions. At the dermo-epidermal junction, and along
hair follicles and sweat ducts, the process contributes to
the formation of nests in an accretive pattern [29]. An
outward transepidermal migration involves single pagetoid
and/ornestedMMcells.TheinvasivepatternofMMinvolves
both the intradermal progression of the primary neoplasm
and the micrometastatic spread. At that stage, MM cells
may be found scattered in the dermis or adjacent to ves-
sels (angiotropism, extravascular migration) or nerves (neu-
rotropism).
These characteristic features probably result from molec-
ular and microstructural determinants. They are in nature
either genetic (gene mutation, deletion, ampliﬁcation, or
translocation) or epigenetic (a heritable change other than
in the DNA sequence, generally transcriptional modulation
by DNA methylation and/or by chromatin alterations such
as histone modiﬁcation) [11]. Abutted to MM, there must
be an adaptive landscape allowing neoplastic cells to adapt
to speciﬁc microenvironmental selection forces [30]. MM
cells must surmount several microenvironmental prolifer-
ation barriers. Somatic progression of invasive MM could
represent a sequence of phenotypical adaptations to these
barriers [14].
During MM progression, diﬀerent molecular mecha-
nisms are distinctly involved. Changes in cell adhesion
molecules are frequently present [31–38]. Secretion of met-
alloproteinases and their inhibitors is involved as well [8,
39]. In addition, macromolecules of the extracellular matrix
(ECM) may be more abundant and possibly produced
by MM cells [40–50]. A biomechanical hypothesis was
oﬀered to explain the MM radical growth phase involving
intercellular/stromal connections [51]. A long wavelength
instability is present at the MM front during the early steps
of MM invasion [51].
TheconceptofMMthigmotropismencompassesthemi-
gration path along the dermo-epidermal and adnexial
basement membranes, as well as the extravascular and
(peri)neural spreads. The involvement of MM stem cells in
thethigmotropicprocessisunknown.Thescatteredintraepi-
dermal and intradermal spread do not follow structured
anatomical supports and thus do not meet the deﬁnition of
thigmotropism.Thepossibleinterventionofimmunecellsin
directing thigmotropism is unsettled.
In incipient MM, neoplastic cells usually migrate ﬁrst
along the basement membrane with focal nest formation.
Such pattern of progression is called atypical melanocytic
hyperplasia. Suprabasal tumor-cell spread in a pagetoid pat-
tern is another characteristic feature commonly found in
superﬁcial spreading MM. Thus, this neoplasm exhibits a
radial growth phase characterized by the presence of severely
atypical melanocytes at and above the dermo-epidermal
junction from where they are scattered throughout the
epidermis[51].TheseMMcellscommonlyhaveanabundant
dusky granular cytoplasm and large pleomorphic and hyper-
chromatic nuclei. Asymmetry, irregular nesting with cellular
discohesion, mitoses, and a prominent band-like lympho-
cytic inﬁltrate are present as well. Immunohistochemistry
using a panel of markers including S100 protein, HMB45,
NKiC3, melan A/MART1, and tyrosinase help in diagnosing
MM with conﬁdence [4]. Occasionally MM show posi-
tive immunolabeling for the epithelial membrane antigen
(EMA), and metastatic MM may show positive staining with
polyclonal antibody to carcinoembryonic antigen (CEA).
3. MM ProgressionandIncipient
Micrometastasis
The MM cell migration potential and the progression to the
fully metastatic cell are complex. Cell adhesion is believed
to play a crucial role in two areas. First, there must be a
loss of adhesion between MM cells at the primary site to
enable individual cells to break free and metastasize. Second,
there must be adhesion between some of these MM cells and
the vascular or lymphatic endothelium and other structures
where the metastasis follows its migration path and is to
become established. Loss of a mediator of tumor cell-cell
interaction or acquisition of a mediator of tumor cell-en-
dothelial cell interaction may therefore be advantageous to
the potentially metastatic MM cell.
Some aspects of MM thigmotropism represent a facet of
theprogressiveextensionoftheprimaryneoplasm.However,
the perivascular spread releases some MM cell aggregates
that are no more in continuity with the main bulk of
the primary lesion. They are viewed as micrometastases.
Theoretically, such aspect may result from two processes. On
the one hand, these microaggregates of MM cells may result
from their migration after leaving their primary location.
This step requires that the MM cells are able to actively
uncouple themselves from neighbouring cells and survive
without the regular cell-to-cell interactions. On the other
hand, they may represent a residual structure left in place
after apoptotic regression of other malignant cells initially
forming a continuous chain connected to the primary
MM, hence being part of it without representing metastatic
deposits. The small groups of clustered surviving cells could
thenbeviewedastheexpressionofsurvivalprivilegeperhaps
related to the MM stem cell status [7, 9].
4.Tropismalong DermoepithelialJunctions
The presence of an increased number of slightly to severely
atypical melanocytes arrayed as solitary cells or clustered
along the dermo-epidermal junction is an established his-
tologic criteria for the diagnosis of atypical melanocytic hy-
perplasia or incipient MM. The same process occurs at the
outer boundaries of the adnexal epithelia. These descriptive
patterns probably result from a peculiar aspect of thig-
motropic MM progression abutted to and restricted to the
dermoepithelial basement membrane zone.Dermatology Research and Practice 3
The intervention of speciﬁc adhesion molecules, par-
ticularly integrin subunits, is likely operative. Integrins are
cell surface proteins that mediate cell-extracellular matrix
adhesion as well as cell-cell adhesion. The transmembrane
cell surface integrins are heterodimers composed of two
diﬀerent subunits. The extracellular part forms the ligand-
binding site, the intracellular portion is bound to the cy-
toskeleton. Thus, it is presumed that integrins form a link
between the cytoskeleton and ECM components inﬂuencing
cell tensegrity and migration as well as tumor growth and
progression. In particular, MM cells show increased α3 β1
integrin expression associated with enhanced invasiveness,
migration, and metastatic potential.
5. AngiotropicMelanoma
In rare instances, MM cells are recognized inside lymphatic
or blood cells. This ﬁnding does not, however, predict the
development of distant overt metastases. Even more rarely,
micrometastases are stuck inside vessel walls. This likely
represents a speciﬁc metastatic homing. A more common
ﬁnding is the extravascular migratory path for metastatic
MM cells [52–55]. Such migration occurs in close contact
with the outer aspect of vessels, inside an amorphous matrix
enriched in basement membrane constituents, particularly
type IV collagen, laminin tenascin, and ﬁbronectin [50, 56–
58]. Such a structure has been called the angiotumoral
complex. Adhesion, proliferation, and migration rate of MM
cells are increased due to these stromal components. Human
endothelial cells represent a boundary during the invasion
and extravasation of MM cells. The α3 integrin receptor
is present on endothelial cells. Adhesion of MM cells to
endothelial cells plays an important role in the metastatic
process. In culture, a low integrin expression rate was
reported to correlate with low adhesion capacity to the ex-
tracellular matrix components and with a weak cell migra-
tion rate [56].
The extracellular migratory MM metastases may be as-
sociated with angiogenic fast-growing MM [46, 59]. An-
giotropism is regarded as a predictor for local recurrence and
in-transit metastasis [60].
6. Neurotropic Melanoma
The desmoplastic and neurotropic MM patterns often occur
together in the same neoplasm [61–63]. The neurotropic
features of the neoplasm are regarded as a crucial clue to the
diagnosis of desmoplastic MM. Neurotropic thigmotropism
is regarded as part of the invasive progression of the primary
MM rather than a step in the metastatic process. The
neurotropic thigmotropism appears to be associated with
speciﬁc markers of the neural crest [64, 65].
7. Thigmotropism and MetastaticHoming
Metastases may, in some instance, remain limited to a
single organ or tissue. Common restricted sites include cu-
taneous metastases. The MM metastatic homing within
the skin is presumably directed, at least in part, by the
thigmotropic migration, particularly in the angiotumoral
complex, allowing a radial intradermal dissemination of
small size metastases. The reason(s) for stopping the thig-
motropic migration and initiating the growth of a metastasis
remain(s)unsettled.Atthatstage,metastaseshaveacquireda
compelling growth preference over the surrounding tissues.
Once cells separate from the primary MM, they must be
functionallyautonomous.Thisrequiresadaptationstomain-
tain continued growth such as the production of autocrine
growth factors and other cellular adaptations promoting
continued survival apart from the primary MM. This feature
could correspond to the conversion of slow-proliferating
stem cells to the ampliﬁcation high rate proliferating cells. A
concurrent or subsequent stage is characterized by a possible
exuberance of blood vascular angiogenesis.
8. Conclusion
Much of the current research in MM therapy is directed
at the mechanisms of metastasis, making knowledge of the
intricacies of this process pertinent. Metastasis is frequently
a subject that conjures up feelings of bewilderment, uncer-
tainty, and confusion. Migration of MM cells along speciﬁc
skin anatomical structures is a common feature similar to
the thigmotropic phenomenon in general biology. It is part
of the progression of the primary neoplasm and to the
initial steps of micrometastasis production. The molecular
mechanisms involved in MM cell migration contribute to a
directed thigmotropic progression along speciﬁc cutaneous
structures. Such features might represent objectives of future
targeted therapies. It remains that studies seeking a correla-
tion between adhesion molecule expression and metastatic
behaviour have yielded conﬂicting results.
Obviously, someinvasive malignant melanomasarelack-
ing competence for metastasis and the disease-free interval is
muchprolonged.ThemicrostagingofpatientswithMMfails
in such instance to distinguish groups of patients at low and
high risk of metastasis.
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